157 related articles for article (PubMed ID: 27659742)
1. [Type I interferonopathies. Literature review].
Picard C; Belot A
Rev Med Interne; 2018 Apr; 39(4):271-278. PubMed ID: 27659742
[TBL] [Abstract][Full Text] [Related]
2. Genetic interferonopathies: An overview.
Eleftheriou D; Brogan PA
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
[TBL] [Abstract][Full Text] [Related]
3. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
Günther C; Schmidt F; König N; Lee-Kirsch MA
Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
[TBL] [Abstract][Full Text] [Related]
4. [When to consider type I interferonopathy in adulthood?].
David C; Frémond ML
Rev Med Interne; 2022 Jun; 43(6):347-355. PubMed ID: 35177256
[TBL] [Abstract][Full Text] [Related]
5. Type I interferonopathies: a novel set of inborn errors of immunity.
Crow YJ
Ann N Y Acad Sci; 2011 Nov; 1238():91-8. PubMed ID: 22129056
[TBL] [Abstract][Full Text] [Related]
6. Type I interferonopathies in pediatric rheumatology.
Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M
Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006
[TBL] [Abstract][Full Text] [Related]
7. Type I interferonopathies: mendelian type I interferon up-regulation.
Crow YJ
Curr Opin Immunol; 2015 Feb; 32():7-12. PubMed ID: 25463593
[TBL] [Abstract][Full Text] [Related]
8. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
Yu ZX; Song HM
World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
[TBL] [Abstract][Full Text] [Related]
9. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
Jiang J; Zhao M; Chang C; Wu H; Lu Q
Clin Rev Allergy Immunol; 2020 Oct; 59(2):248-272. PubMed ID: 32557263
[TBL] [Abstract][Full Text] [Related]
10. Comparison of RT-qPCR and Nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies.
Pescarmona R; Belot A; Villard M; Besson L; Lopez J; Mosnier I; Mathieu AL; Lombard C; Garnier L; Frachette C; Walzer T; Viel S
Cytokine; 2019 Jan; 113():446-452. PubMed ID: 30413290
[TBL] [Abstract][Full Text] [Related]
11. Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.
Kim H; Sanchez GA; Goldbach-Mansky R
J Mol Med (Berl); 2016 Oct; 94(10):1111-1127. PubMed ID: 27678529
[TBL] [Abstract][Full Text] [Related]
12. Novel interferonopathies associated with mutations in RIG-I like receptors.
Buers I; Nitschke Y; Rutsch F
Cytokine Growth Factor Rev; 2016 Jun; 29():101-7. PubMed ID: 26993858
[TBL] [Abstract][Full Text] [Related]
13. The Type I Interferonopathies.
Lee-Kirsch MA
Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
[TBL] [Abstract][Full Text] [Related]
14. Type I interferonopathies--an expanding disease spectrum of immunodysregulation.
Lee-Kirsch MA; Wolf C; Kretschmer S; Roers A
Semin Immunopathol; 2015 Jul; 37(4):349-57. PubMed ID: 25998914
[TBL] [Abstract][Full Text] [Related]
15. [Type I interferonopathies].
Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Approaches to Type I Interferonopathies.
Bienias M; Brück N; Griep C; Wolf C; Kretschmer S; Kind B; Tüngler V; Berner R; Lee-Kirsch MA
Curr Rheumatol Rep; 2018 Apr; 20(6):32. PubMed ID: 29679241
[TBL] [Abstract][Full Text] [Related]
17. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.
Melki I; Frémond ML
Curr Rheumatol Rep; 2020 Jun; 22(7):32. PubMed ID: 32548765
[TBL] [Abstract][Full Text] [Related]
18. Does type-I interferon drive systemic autoimmunity?
Picard C; Belot A
Autoimmun Rev; 2017 Sep; 16(9):897-902. PubMed ID: 28694138
[TBL] [Abstract][Full Text] [Related]
19. The importance of the type I interferon system in autoimmunity.
Rönnblom L
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):21-4. PubMed ID: 27586799
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
